CTAB Lysis Reagent for rAAV Vector Recovery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying recombinant adeno-associated virus (rAAV) vectors face challenges due to binding of capsids with positively charged surface residues to negatively charged cell material, leading to reduced recovery, especially for serotypes like AAV3B, AAV6, and AAV13, which have high affinity for heparan sulfate proteoglycan receptors.
Innovation Solution
A method using cetyltrimethylammonium bromide (CTAB) as a single reagent for both cell lysis and flocculation, reducing reagent quantity and processing time, and avoiding the need for settling, thereby enhancing the recovery of rAAV vectors by minimizing their interaction with cell debris.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional cell lysis detergents like octoxynol-9 are used, then cell lysis is effective, but the process requires high concentrations (0.1%-0.5% w/v) and extended time, and environmental concerns limit their use
Solution Approach 1:
The patent changes the chemical parameters of the lysis reagent by using CTAB at much lower concentrations (0.001%-0.1% w/v) compared to traditional detergents. This parameter change achieves effective cell lysis while reducing processing time and eliminating environmental concerns associated with conventional detergents like octoxynol-9
Solution Approach 2:
CTAB serves multiple functions simultaneously: it acts as a cell lysis agent, a flocculation reagent for DNA precipitation, and a detergent for removing cell debris. This multi-functionality consolidates multiple steps into one, reducing overall processing time while maintaining effective cell lysis
2Reliability
If DNAse enzyme like Benzonase is used for DNA degradation, then nucleic acid is effectively degraded, but the enzyme has low tolerance to high salt concentrations and is relatively expensive
Solution Approach 1:
The patent replaces the enzymatic mechanism (DNAse/Benzonase) with a chemical mechanism using CTAB. CTAB precipitates DNA through chemical interaction with the phosphate backbone, forming insoluble complexes that can be removed by filtration or centrifugation. This substitution eliminates salt concentration limitations and reduces cost while maintaining effective DNA degradation
Solution Approach 2:
The patent changes the mechanism of DNA removal from enzymatic degradation to chemical precipitation. CTAB forms insoluble complexes with DNA that can be removed physically, allowing the process to proceed in high salt conditions where enzymes would be inactive, thus improving adaptability to different buffer conditions
3Productivity
If rAAV vectors with positively charged surface residues are purified, then vector production is achieved, but capsids bind to negatively charged cell material reducing recovery
Solution Approach 1:
The patent converts the harmful electrostatic interaction between positively charged capsids and negatively charged cell material into a beneficial process. By adding CTAB, which binds to cell debris and forms precipitates, the harmful binding is converted into a selective precipitation process where cell debris is removed while capsids remain in solution, actually improving recovery
Solution Approach 2:
CTAB acts as an intermediary substance that mediates between the capsids and cell debris. It binds preferentially to cell debris and precipitates it, preventing direct interaction between capsids and cell material. This intermediary action selectively removes contaminants while preserving vector recovery
4Reliability
If multiple reagents are used for lysis and flocculation, then comprehensive cell disruption is achieved, but processing complexity and time increase
Solution Approach 1:
The patent merges the functions of cell lysis and flocculation into a single step using CTAB. The reagent simultaneously disrupts cell membranes and precipitates cellular debris, eliminating the need for separate lysis and flocculation steps. This consolidation reduces processing complexity while maintaining complete cell disruption
Solution Approach 2:
CTAB is a universal reagent that performs multiple functions: cell membrane disruption, DNA precipitation, and cell debris flocculation. This multi-functionality allows a single reagent to replace multiple specialized reagents, simplifying the overall process while achieving comprehensive cell disruption
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly increases the recovery of rAAV vectors by up to 1.5 to 10-fold compared to traditional methods, producing a clarified lysate with higher vector genomes and reduced host cell DNA contamination, facilitating more efficient downstream purification.
Implementation Method 1
Cell lysis may occur either by chemical lysis (e.g. pH, detergent, high osmolality solution) or physical lysis
Implementation Method 2
treatment with a detergent which causes flocculation of the contaminants. A commonly used flocculant is domiphen bromide (DB), a positively charged quaternary ammonium compound that binds negatively charged DNA. During flocculation, host cell DNA (HCDNA) and host cell protein (HCP) precipitate and settle out of solution as a flocculant mass
Implementation Method 3
The supernatant, which contains the molecules of interest (e.g., rAAV vectors), is more efficiently filtered to produce a clarified lysate solution following the flocculation
Data Source
AI summary
The present disclosure describes improved methods for use in purifying biological products made by host cells. In some embodiments, the improved methods comprise one or more steps of lysing host cells to release the biological product and precipitating host cell DNA, using a detergent such as cetyltrimethylammonium bromide (CTAB). In some embodiments, the biological product is a vaccine, or a viral vector for gene therapy, such as an AAV vector or a lentiviral vector.